CDSCO Panel Recommends Protocol Amendment for Novartis' Ianalumab Trial Farhat Nasim21 May 2025 8:03 PM ISTNew Delhi: The Subject Expert Committee (SEC) on Haematology, functional under the Central Drugs Standard Control Organisation (CDSCO) has recommended...
CDSCO panel Approves Astrazeneca Pharma India's Protocol Amendment proposal to study Durvalumab-Tremelimumab Dr. Divya Colin17 May 2025 6:30 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has approved Astrazeneca Pharma...
CDSCO Panel Approves Novartis' Protocol Amendment proposal for Iptacopan Clinical study in Kidney Disorders Dr. Divya Colin10 May 2025 6:00 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has approved the proposal...
CDSCO Panel Approves Dr Reddy's Laboratories Protocol Amendment Proposal to study Abatacept Dr. Divya Colin3 May 2025 5:45 PM ISTNew Delhi: The Subject Expert Committee (SEC), functional under the Central Drug Standard Control Organisation (CDSCO), has approved Dr Reddys...
CDSCO Panel Approves Novartis Healthcare's Protocol Amendment to study Iptacopan Dr. Divya Colin3 May 2025 5:30 PM ISTNew Delhi: The Subject Expert Committee (SEC), functional under the Central Drug Standard Control Organization (CDSCO), has approved the protocol...
CDSCO Panel Approves Sanofi's Protocol Amendment to study Tolebrutinib Dr. Divya Colin20 April 2025 5:15 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organization (CDSCO) has approved Sanofi's proposal...
CDSCO Panel Approves Novartis Protocol Amendment Proposal fo Ianalumab study Dr. Divya Colin2 April 2025 5:30 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has approved the protocol...
CDSCO Panel Approves Bristol Myers Squibb's Protocol Amendment Proposal to study Anti-cancer Drug Iberdomide Dr. Divya Colin21 March 2025 6:00 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has approved the Bristol Myers...
CDSCO Panel Approves Johnson and Johnson's Protocol Amendment proposal for Teclistamab study Dr. Divya Colin2 March 2025 5:30 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has approved Johnson and...
CDSCO Panel Approves Novo Nordisk Proposal Amendment Proposal for Etavopivat study Dr. Divya Colin9 Feb 2025 5:45 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has approved the protocol...
CDSCO Approves Novo Nordisk Protocol Amendment Proposal for Concizumab study Dr. Divya Colin7 Feb 2025 6:00 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has approved the protocol...
CDSCO Panel Approves AstraZeneca's Protocol Amendment Proposal for Anti-cancer Drug Volrustomig study Dr. Divya Colin22 Jan 2025 5:45 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has approved the protocol...
